Health
First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease – UC San Diego Health
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into…
Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
The protein, called brain-derived neurotrophic factor or BDNF, is part of a family of growth factors found in the brain and central nervous system that support…
-
Noosa News24 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News23 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business22 hours ago3 steps to take to build a $1,000 monthly passive income
-
Noosa News24 hours agoOats free of gluten contaminants can’t be labelled gluten-free